Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro ...
Implementing Digital pathology and AI in cancer diagnosis alleviates impact of pathologist shortage through improved workflow and remote collaboration capabilities ...
Arkansas State University’s Department of Communication Disorders has established an ALLIANCE Lab to assist children with learning difficulties.
Agilent Technologies has agreed to buy pathology company Biocare Medical in an all-cash deal valued at $950 million that bolsters its immunohistochemistry offering.
Advanced Testing to cut patient costs, delays’ Irfan Tramboo SRINAGAR, Mar 9: Sher-e-Kashmir Institute of Medical Sciences (SKIMS) today inaugurated a comprehensive panel of 174 Immunohistochemistry ...
Agilent Technologies Inc. A shares are up during Monday’s premarket session as the company announces the acquisition of Biocare Medical for around $950 million. Synergies Biocare Medical has been a ...
Agilent Technologies said that it will acquire privately held clinical pathology firm Biocare Medical in an all-cash deal of $950 million ...
A new study finds AI can potentially detect artery calcification in routine mammograms, helping identify women at risk of ...
The Dubbo community will benefit from an $8.2 million investment by the Minns Labor Government to deliver major upgrades to NSW Health Pathology's laboratory at Dubbo Health Service. The brand-new, ...
North Shore University Hospital has started using a new rapid blood test that can help emergency department physicians ...
Abdel-Rahman and colleagues highlighted important challenges facing the oncology workforce.[1][1] Advances in targeted therapies and immunotherapies have improved patient survival and increased demand ...
Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results